Application of metal-organic frameworks-based drug delivery for different diseases treatment

Jingya Ji; Yaming Liu; Yameng Wang; Wenjing Yao

doi:10.54097/hset.v33i.5304

Authors

Jingya Ji
Yaming Liu
Yameng Wang
Wenjing Yao

DOI:

https://doi.org/10.54097/hset.v33i.5304

Keywords:

Drug delivery; MOFs; functional materials; disease treatment; application.

Abstract

The limitations of traditional drug delivery vehicles include low specificity, uncontrolled biodegradation, and are oftentimes associated with toxicity and serious off-target events. In addressing the biological relevance of an effective drug delivery system in improving the therapeutic efficacy of active ingredients, a variety of new approaches for drug administration have recently been developed. Remarkable breakthroughs following the emergence of nanotechnologies promoted metal-organic frameworks (MOFs) as viable drug delivery possibilities. They are characterised by large surface area and porosities, and hence, exceptional drug adsorption ability. Inorganic MOFs in particular offer high drug loadings and functionalisation capacity, enabling a high-efficacy drug administration route and controlled pattern of drugs’ in vivo behaviours. This research encompasses the preparation of MOFs and their relevant drug delivery for different diseases treatment in biomedical field, which are classified according to four types of diseases including cancer, Alzheimer’s disease, pulmonary diseases, and ocular diseases. A diverse of different MOFs have been designed to treat given their corresponding properties for these diseases. Experimental outcomes from each research are also analysed to evaluate the therapeutic effectiveness and biological applicability of proposed MOFs, which is expected to provide a new idea for efficient drug delivery in disease treatment.

Downloads

Download data is not yet available.

References

Lázaro, I. A., & Forgan, R. S. (2019). Application of zirconium MOFs in drug delivery and biomedicine. Coordination Chemistry Reviews, 380: 230-259.

Rojas, S., Arenas-Vivo, A., Horcajada, P. (2019). Metal-organic frameworks: A novel platform for combined advanced therapies. Coordination Chemistry Reviews, 388: 202-226.

Bjork, E.M., Baumann, B., Hausladen, F., Wittig, R., Linden, M. (2019). Cell adherence and drug delivery from particle based mesoporous silica films. RSC Adv., 9: 17745-17753.

Strzempek, W., Menaszek, E., Gil, B. (2019). Fe-MIL-100 as drug delivery system for asthma and chronic obstructive pulmonary disease treatment and diagnosis. Microporous and Mesoporous Materials, 280: 264-270.

Jarai, B.M., Stillman, Z., Attia, L., Decker, G.E., Bloch, E.D., Fromen, C.A. (2020). Evaluating UiO-66 Metal–Organic Framework Nanoparticles as Acid-Sensitive Carriers for Pulmonary Drug Delivery Applications. ACS Appl. Mater. Interfaces, 12: 38989-39004.

Mohamed, N.A., Abou-Saleh, H., Kameno, Y. et al. (2021). Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension. Sci. Rep., 11: 4336.

Zheng, H., Zhang, Y., Liu, L., Wei, W., Peng, G., & Nystroem, A. M. et al. (2016). One-pot synthesis of metal-organic frameworks with encapsulated target molecules and their applications for controlled drug delivery. Journal of the American Chemical Society, 138(3), 962-968.

Mallakpour, S., Nikkhoo, E., & Hussain, C. M. (2022). Application of mof materials as drug delivery systems for cancer therapy and dermal treatment. Coordination Chemistry Reviews, 451, 214262.

Xie, C., Guo, B., You, H., Wang, Z., Leng, Q., Ding, L. ET. Al. (2021). Synthesis and surface modification of mesoporous metal-organic framework (uio-66) for efficient ph-responsive drug delivery and lung cancer treatment. Nanotechnology, 32(29), 295704.

Zhao, J., Yin, F., Ji, L., Wang, C., Shi, C., Liu, X., Yang, H., Wang, X., & Kong, L. (2020). Development of a Tau-Targeted Drug Delivery System Using a Multifunctional Nanoscale Metal–Organic Framework for Alzheimer’s disease Therapy. ACS applied materials & interfaces, 12(40), 44447-44458.

Wang, J., Fan, Y., Tan, Y., Zhao, X., Zhang, Y., Cheng, C., & Yang, M. (2018). Porphyrinic metal–organic framework PCN-224 nanoparticles for near-infrared-induced attenuation of aggregation and neurotoxicity of Alzheimer’s amyloid-β peptide. ACS applied materials & interfaces, 10(43), 36615-36621.

Yu, D., Ma, M., Liu, Z., Pi, Z., & Qu, X. (2020). MOF-encapsulated nanozyme enhanced sirna combo: control neural stem cell differentiation and ameliorate cognitive impairments in alzheimer’s disease model. Biomaterials, 255, 120160.

Gandara-Loe J., Souza B.E., Missyul A., Giraldo G., Tan J.C., Silvestre-Albero J. (2020). MOF-Based Polymeric Nanocomposite Films as Potential Materials for Drug Delivery Devices in Ocular Therapeutics. ACS Appl. Mater. Interfaces, 12(27), 30189-30197.